100 related articles for article (PubMed ID: 1426008)
1. Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responses.
Douglas SA; Elliott JD; Ohlstein EH
Eur J Pharmacol; 1992 Oct; 221(2-3):315-24. PubMed ID: 1426008
[TBL] [Abstract][Full Text] [Related]
2. Discrimination between ETA- and ETB-receptor-mediated effects of endothelin-1 and [Ala1,3,11,15]endothelin-1 by BQ-123 in the anaesthetized rat.
Bigaud M; Pelton JT
Br J Pharmacol; 1992 Dec; 107(4):912-8. PubMed ID: 1467841
[TBL] [Abstract][Full Text] [Related]
3. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
Allcock GH; Warner TD; Vane JR
Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
[TBL] [Abstract][Full Text] [Related]
4. Implication of different endothelin receptors in the vascular action of a hypertensive dose of ET-1 in rat.
Cornet S; Pirotzky E; Braquet P
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S239-42. PubMed ID: 7509955
[TBL] [Abstract][Full Text] [Related]
5. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T; Davenport AP; Edvinsson L
Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866
[TBL] [Abstract][Full Text] [Related]
6. Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor.
McMurdo L; Corder R; Thiemermann C; Vane JR
Br J Pharmacol; 1993 Feb; 108(2):557-61. PubMed ID: 8448603
[TBL] [Abstract][Full Text] [Related]
7. Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat.
Cristol JP; Warner TD; Thiemermann C; Vane JR
Br J Pharmacol; 1993 Mar; 108(3):776-9. PubMed ID: 8467364
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670.
Douglas SA; Edwards RM; Elliott JD; Ohlstein EH
Br J Pharmacol; 1995 Jan; 114(2):405-13. PubMed ID: 7881741
[TBL] [Abstract][Full Text] [Related]
9. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.
Pollock DM; Opgenorth TJ
Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752
[TBL] [Abstract][Full Text] [Related]
10. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
[TBL] [Abstract][Full Text] [Related]
11. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
Warner TD; Allcock GH; Vane JR
Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
[TBL] [Abstract][Full Text] [Related]
12. Endothelin receptor mediated constriction and dilatation in feline cerebral resistance arterioles in vivo.
Patel TR; McAuley MA; McCulloch J
Eur J Pharmacol; 1996 Jun; 307(1):41-8. PubMed ID: 8831102
[TBL] [Abstract][Full Text] [Related]
13. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
Warner TD; Allcock GH; Corder R; Vane JR
Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
[TBL] [Abstract][Full Text] [Related]
14. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat.
Gellai M; Fletcher T; Pullen M; Nambi P
Am J Physiol; 1996 Jul; 271(1 Pt 2):R254-61. PubMed ID: 8760228
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ETB receptors limits the efficacy of nonselective endothelin antagonists in vivo.
Allcock GH; Warner TD
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S177-9. PubMed ID: 8587355
[TBL] [Abstract][Full Text] [Related]
17. ETA-dependent pressor effects and release of prostacyclin induced by endothelins in pulmonary and renal vasculature.
D'Orléans-Juste P; Yano M; Télémaque S
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S235-8. PubMed ID: 7509954
[TBL] [Abstract][Full Text] [Related]
18. Systemic hemodynamic and regional circulatory effects of centrally administered endothelin-1 are mediated through ETA receptors.
Rebello S; Roy S; Saxena PR; Gulati A
Brain Res; 1995 Apr; 676(1):141-50. PubMed ID: 7796163
[TBL] [Abstract][Full Text] [Related]
19. Endothelin receptor subtypes in the pathogenesis of angioplasty-induced neointima formation in the rat: a comparison of selective ETA receptor antagonism and dual ETA/ETB receptor antagonism using BQ-123 and SB 209670.
Douglas SA; Vickery-Clark LM; Louden C; Elliott JD; Ohlstein EH
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S186-9. PubMed ID: 8587358
[TBL] [Abstract][Full Text] [Related]
20. Effects of the endothelin (ET) receptor antagonist BQ 123 on initial and delayed vascular responses induced by ET-1 in conscious, normotensive rats.
Bird JE; Waldron TL; Dorso CR; Asaad MM
J Cardiovasc Pharmacol; 1993 Jul; 22(1):69-73. PubMed ID: 7690099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
